GB1269908A - Amino acids having anti-viral effects - Google Patents

Amino acids having anti-viral effects

Info

Publication number
GB1269908A
GB1269908A GB42828/70A GB4282870A GB1269908A GB 1269908 A GB1269908 A GB 1269908A GB 42828/70 A GB42828/70 A GB 42828/70A GB 4282870 A GB4282870 A GB 4282870A GB 1269908 A GB1269908 A GB 1269908A
Authority
GB
United Kingdom
Prior art keywords
compounds
amino acids
fluorenesulphonyl
nitrophenylalanine
sept
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB42828/70A
Other languages
English (en)
Inventor
Shigeshi Toyoshima
Seizo Kanao
Takeshi Toyoda
Tadashi Suyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to GB1288020D priority Critical patent/GB1288020A/en
Publication of GB1269908A publication Critical patent/GB1269908A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB42828/70A 1969-09-06 1970-09-07 Amino acids having anti-viral effects Expired GB1269908A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1288020D GB1288020A (https=) 1969-09-06 1970-09-07

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7071669 1969-09-06

Publications (1)

Publication Number Publication Date
GB1269908A true GB1269908A (en) 1972-04-06

Family

ID=13439555

Family Applications (1)

Application Number Title Priority Date Filing Date
GB42828/70A Expired GB1269908A (en) 1969-09-06 1970-09-07 Amino acids having anti-viral effects

Country Status (5)

Country Link
US (1) US3801633A (https=)
DE (1) DE2043933C3 (https=)
FR (1) FR2070675B1 (https=)
GB (1) GB1269908A (https=)
NL (1) NL7013043A (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU735013B2 (en) * 1996-09-04 2001-06-28 Warner-Lambert Company Matrix metalloproteinase inhibitors and their therapeutic uses
MD4110C1 (ro) * 2010-10-21 2011-12-31 Валериу РУДИК Preparat antiherpetiс

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4165258A (en) * 1975-10-08 1979-08-21 University Of Pennsylvania Plasminogen activating enzyme-specific competitive inhibitor
US4070478A (en) * 1977-02-17 1978-01-24 Merck & Co., Inc. Benzimidazole substituted alanines
FR2508444A1 (fr) * 1981-06-29 1982-12-31 Irceba Nouveaux derives sulfonyle du tryptophane utiles en tant que medicaments et leur procede de preparation
US5079260A (en) * 1989-06-22 1992-01-07 Nova Pharmaceutical Corporation Method for treating inflammation and compounds and compositions suitable for use therein
US5472973A (en) * 1991-12-12 1995-12-05 Scios Nova Inc. Fluorenyl derivatives as anti-inflammatory agents
WO1993011764A1 (en) * 1991-12-12 1993-06-24 Scios Nova Inc. Fluorenyl derivatives and their use as anti-inflammatory agents
WO2013148991A1 (en) 2012-03-30 2013-10-03 Givaudan S.A. N-acyl derivatives of gamma amino - butyric acid and and beta alanine as food flavouring compounds
EP2830438B1 (en) 2012-03-30 2019-09-04 Givaudan SA N-acyl derivatives of gamma amino-butyric acid as food flavouring compounds, powder compositions containing them
US10913922B2 (en) 2012-03-30 2021-02-09 Givaudan S.A. N-acylated methionine derivatives as food flavoring compounds
BR112014023959B1 (pt) 2012-03-30 2020-10-20 Givaudan Sa composição comestível
SG11201405104PA (en) 2012-03-30 2014-10-30 Givaudan Sa Improvements in or relating to organic compounds
EP2830437B1 (en) 2012-03-30 2018-12-26 Givaudan SA N-acylated 1-aminocycloalkyl carboxylic acids as food flavouring compounds
CN104219964B (zh) 2012-03-30 2016-09-21 奇华顿股份有限公司 作为食品加香化合物的n-酰基脯氨酸衍生物
WO2015050536A1 (en) 2013-10-02 2015-04-09 Givaudan S.A. N-acylated 2-aminoisobutyric acid compounds and flavour compositions containing them
US10674755B2 (en) 2013-10-02 2020-06-09 Givaudan S.A. Organic Compounds
WO2015050537A1 (en) 2013-10-02 2015-04-09 Givaudan S.A. Organic compounds
EP3057444B1 (en) 2013-10-02 2017-12-06 Givaudan SA Organic compounds having taste-modifying properties
GB201317424D0 (en) 2013-10-02 2013-11-13 Givaudan Sa Improvements in or relating to organic compounds
EP3057445B1 (en) 2013-10-02 2018-07-04 Givaudan SA Organic compounds having taste-modifying properties
WO2015050538A1 (en) * 2013-10-02 2015-04-09 Givaudan S.A. Organic compounds
WO2015050535A1 (en) 2013-10-02 2015-04-09 Givaudan S.A. Organic compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU735013B2 (en) * 1996-09-04 2001-06-28 Warner-Lambert Company Matrix metalloproteinase inhibitors and their therapeutic uses
MD4110C1 (ro) * 2010-10-21 2011-12-31 Валериу РУДИК Preparat antiherpetiс

Also Published As

Publication number Publication date
DE2043933C3 (de) 1978-05-18
FR2070675A1 (https=) 1971-09-17
DE2043933A1 (de) 1971-03-11
DE2043933B2 (de) 1977-09-08
NL7013043A (https=) 1971-03-09
FR2070675B1 (https=) 1974-09-27
US3801633A (en) 1974-04-02

Similar Documents

Publication Publication Date Title
GB1269908A (en) Amino acids having anti-viral effects
GB1411583A (en) Aminophenyl-substituted alkyl-heterocyclic derivatives and processes for producing them
GB1252329A (https=)
GB1291442A (en) Adamantylamino-5,8-dihydronaphthyloxy-propanols and related compounds
IE33371L (en) Protozoacids; aminoguanidine derivatives
GB1359560A (en) Preparation of pyrrylsalicylic acid
GB1342760A (en) Substituted phthalazines
GB1243953A (en) Benzdiazepine derivatives
GB1332959A (en) Process for preparing derivatives of imidazoline
GB1494299A (en) Propionic acid derivative salts having hiperlipemic activity
GB1449426A (en) Phenoxyalkylamine derivatives and preparation therof
GB1254270A (en) Benzoxazepine derivatives
GB1276061A (en) Tetronic acid derivatives, process for the manufacture thereof, and compositions containing such compounds
GB1263116A (en) Chloramphenicol and thiamphenicol derivatives
GB1299566A (en) Bis-basic ethers of 2,6- and 2,7-dihydroxyanthraquinones
GB1286945A (en) Indoline-2-one derivatives and preparation thereof
GB1383259A (en) 5-hydroxy-1- -5-substituted phenyl furfurylidene- amino - hydantoins
GB1230468A (https=)
GB1397675A (en) Proline compounds
GB1339010A (en) Tetrazolyl-anthraquinone derivatives
GB1416831A (en) Dihydroxydiphenylmethane derivatives
GB1209138A (en) IMPROVEMENTS IN OR RELATING TO A NEW alpha-NAPHTHOXY-ISOBUTYRIC ACID DERIVATIVE, PROCESS FOR ITS PREPARATION AND THERAPEUTICAL COMPOSITION CONTAINING SAME
ES424362A1 (es) Un proceso para la preparacion y estabilizacion de una com-posicion oftalmica, administrable topicamente.
GB1264261A (https=)
GB1462350A (en) 2-piperazinyl-thiazole derivative